Missverständnisse in der Typ-2-Diabetologie und deren Folgen – Kritischer Blick auf Diagnostik und Therapie

Die Typ-2-Diabetologie wird mit einer stetig wachsenden Anzahl an Betroffenen, die bereits frühzeitig komplexe kardiovaskuläre Komplikationen aufweisen und durch die bislang etablierten Therapiekonzepte nur unzureichend vor diesen Komplikationen geschützt sind, konfrontiert. Die Konsequenzen dieser Situation sind sowohl gesundheitspolitisch, wirtschaftlich wie medizinisch problematisch. Auf Basis pathophysiologischer Erkenntnisse der Krankheitsentstehung sollten bislang etablierte Schritte zur Diagnostik und Therapie, insbesondere eine bessere Berücksichtigung von Lebenstilmaßnahmen wie körperlichem Training, kritisch überdacht werden.

Type 2 diabetology is being confronted with an ever increasing number of patients who exhibit complex cardiovascular complications already in the early stages and who cannot be adequately protected from such complications by the currently established therapeutic concepts. The consequences of this situation are not only health-political but also economic and medical problems. On the basis of our pathophysiological understanding about the occurrence of diseases, the currently established steps in diagnosis and therapy, especially under consideration of life-style interventions such as physical training, should be critically reevaluated.

Key Words

diabetes type 2 - diagnostics - therapeutic concepts - life-style interventions - physical training

• Literatur

• Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Nathan DM, Zinman B, Cleary PA et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med 2009; 169: 1307-1316
• Ray KK, Seshasai SR, Wijesuriya S et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009; 373: 1765-1772
• Hu FB, Stampfer MJ, Haffner SM et al. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002; 25: 1129-1134
• Holterhus PM, Beyer P, Bürger-Büsing J et al. Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter. Evidenzbasierte Diabetes-Leitlinie DDG. www.deutsche-diabetes-gesellschaft.de/leitlinien/EBL_Kindesalter_2009.pdf
• UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 1990; 13: 1-11
• Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007; 28: 88-136
• Polonsky KS, Sturis J, Bell GI. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. New Engl J Med 1996; 334: 777-783
• Olson DE, Rhee MK, Herrick K et al. Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 2010; 33: 2184-2189
• Staiger H, Machicao F, Fritsche A, Häring HU. Pathomechanisms of type 2 diabetes genes. Endocr Rev 2009; 30: 557-585
• Aas AM, Bergstad I, Thorsby PM et al. An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study. Diabet Med 2005; 22: 316-322
• Worms F, Philipp A, Hinck V, Lundershausen R. Fastentests bei insulinbehandelten Typ 2 Diabetikern. Diabetes und Stoffwechsel 2002; 11: 273-278
• Schauer PR, Burguera B, Ikramuddin S et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-484
• Petrella RJ, Lattanzio CN, Demeray A, Varallo V, Blore R. Can adoption of regular exercise later in life prevent metabolic risk for cardiovascular disease?. Diabetes Care 2005; 28: 694-701
• Jonker JT, De Laet C, Franco OH et al. Physical activity and life expectancy with and without diabetes: life table analysis of the Framingham Heart Study. Diabetes Care 2006; 29: 38-43
• Kirwan JP, del Aguila LF, Hernandez JM et al. Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle. J Appl Physiol 2000; 88: 797-803
• Levy P. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease. Postgrad Med 2009; 121 (Suppl. 01) 7-12
• Sigal RJ, Wasserman DH, Kenny GP, Castaneda-Sceppa C. Physical activity/exercise and type 2 diabetes. Technical review. Diabetes Care 2004; 27: 2518-2539
• Hansen D, Dendale P, Jonkers RA et al. Continuous low- to moderate-intensity exercise training is as effective as moderate- to high-intensity exercise training at lowering blood HbA(1c) in obese type 2 diabetes patients. Diabetologia 2009; 52: 1789-1797
• Rabøl R, Boushel R, Dela F. Mitochondrial oxidative function and type 2 diabetes. Appl Physiol Nutr Metab 2006; 31: 675-683